JP2007518732A5 - - Google Patents

Download PDF

Info

Publication number
JP2007518732A5
JP2007518732A5 JP2006548383A JP2006548383A JP2007518732A5 JP 2007518732 A5 JP2007518732 A5 JP 2007518732A5 JP 2006548383 A JP2006548383 A JP 2006548383A JP 2006548383 A JP2006548383 A JP 2006548383A JP 2007518732 A5 JP2007518732 A5 JP 2007518732A5
Authority
JP
Japan
Prior art keywords
polymer
organisms
complex
pathogenic
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006548383A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007518732A (ja
Filing date
Publication date
Priority claimed from GBGB0400264.8A external-priority patent/GB0400264D0/en
Application filed filed Critical
Publication of JP2007518732A publication Critical patent/JP2007518732A/ja
Publication of JP2007518732A5 publication Critical patent/JP2007518732A5/ja
Pending legal-status Critical Current

Links

JP2006548383A 2004-01-07 2005-01-07 アジュバント活性を有する複合体 Pending JP2007518732A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0400264.8A GB0400264D0 (en) 2004-01-07 2004-01-07 Complexes
PCT/GB2005/000039 WO2005065712A2 (en) 2004-01-07 2005-01-07 Complexes having adjuvant activity

Publications (2)

Publication Number Publication Date
JP2007518732A JP2007518732A (ja) 2007-07-12
JP2007518732A5 true JP2007518732A5 (enExample) 2008-02-07

Family

ID=31503533

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006548383A Pending JP2007518732A (ja) 2004-01-07 2005-01-07 アジュバント活性を有する複合体

Country Status (10)

Country Link
US (1) US20090176866A1 (enExample)
EP (1) EP1701741B1 (enExample)
JP (1) JP2007518732A (enExample)
CN (1) CN1909928B (enExample)
AT (1) ATE396742T1 (enExample)
AU (1) AU2005203908B2 (enExample)
DE (1) DE602005007177D1 (enExample)
ES (1) ES2308432T3 (enExample)
GB (1) GB0400264D0 (enExample)
WO (1) WO2005065712A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316294D0 (en) 2003-07-11 2003-08-13 Polytherics Ltd Conjugated biological molecules and their preparation
GB0722080D0 (en) * 2007-11-09 2007-12-19 Polytherics Ltd Novel complexes and a process for their preparation
MX344076B (es) 2008-06-30 2016-12-05 Esbatech Alcon Biomed Res Unit Polipeptidos funcionalizados.
US8697074B2 (en) 2008-07-10 2014-04-15 Esbatech, An Alcon Biomedical Research Unit Llc Methods and compositions for enhanced delivery of macromolecules
GB201210358D0 (en) * 2012-06-12 2012-07-25 Polytherics Ltd Complexes
DK3471760T3 (da) 2016-06-17 2025-01-27 Boehringer Ingelheim Vetmedica Gmbh Hidtil ukendte immunogene formuleringer, der omfatter lineære eller forgrenede polyacrylsyrepolymeradjuvanser

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
US5130126A (en) * 1990-07-09 1992-07-14 Nippon Oil & Fats Co., Ltd. Polymer-drug conjugate and a method of producing it
CA2072072A1 (en) * 1990-10-24 1992-04-25 Eisai Co., Ltd. Organic polymer compound and production thereof
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
GB2290707A (en) * 1994-06-28 1996-01-10 Georgi Stankov Pharmaceutical uses of Amphotericin B
CA2299117A1 (en) * 1999-02-24 2000-08-24 Stiefel Research Institute, Inc. Antimycotic compositions
EP1222217B1 (en) * 1999-09-08 2005-06-15 Polytherics Limited Uniform molecular weight polymers
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
EP1383376A4 (en) * 2001-03-19 2006-03-08 Praecis Pharm Inc PHARMACEUTICAL FORMULATIONS WITH PROLONGED RELEASE
BR0105500A (pt) * 2001-11-05 2004-06-22 Univ Minas Gerais Processo de obtenção de dispersões coloidais de anfotericina b; composições à base de anfotericina b de uso enteral, parenteral e tópico; uso destas composições no tratamento de micoses sistêmicas e infecções parasitárias

Similar Documents

Publication Publication Date Title
US8324333B2 (en) Anionic charge-dynamic polymers for release of cationic agents
JP6175451B2 (ja) ポリマー担体カーゴ複合体と少なくとも１つのタンパク質又はペプチド抗原とを含む医薬組成物
Lin et al. Enhanced immune responses to mucosa by functionalized chitosan-based composite nanoparticles as a vaccine adjuvant for intranasal delivery
JP5349318B2 (ja) ステロイド類の高分子結合体
Gambaryan et al. Polymeric inhibitor of influenza virus attachment protects mice from experimental influenza infection
JP2019509339A5 (enExample)
JP2012017342A5 (enExample)
CA2637765A1 (en) Benzamide and heteroarene derivatives
WO2021216467A1 (en) A nano-enabled vaccination approach for coronavirus disease (covid-19) and other viral diseases
Desai et al. Nanoadjuvants: promising bioinspired and biomimetic approaches in vaccine innovation
Hsu et al. Polyphosphazenes for the delivery of biopharmaceuticals
Yu et al. Quaternized chitosan nanoparticles in vaccine applications
Orosco et al. Navigating the landscape of adjuvants for subunit vaccines: recent advances and future perspectives
CN112839674B (zh) 包含抗原肽-佐剂核苷酸缀合体的免疫诱导剂及包含其的药物组合物
CA2840974A1 (en) Vaccine composition for mucosal administration
JP2007518732A5 (enExample)
JP5249041B2 (ja) ビスアシルオキシプロピルシステイン複合体に基づく新規なアジュバント及び誘導体並びに医薬組成物におけるその使用
Akilesh M et al. Novel applications of nanotechnology in controlling HIV and HSV infections
Liu et al. Polymeric nanoparticles engineered as a vaccine adjuvant-delivery system
WO2013024859A1 (ja) 分子擬態粘膜エイズワクチン
EP1701741B1 (en) Complexes having adjuvant activity
JP2020182486A5 (enExample)
JP6559898B2 (ja) スクアレンを含む両親媒性ポリアミノ酸高分子に基づくワクチンの免疫補助剤組成物
JP2012526847A5 (enExample)
JP4707107B2 (ja) ジシアロウンデカ糖鎖アスパラギン−脂肪酸アミド、これを含む医薬